Fulvestrant
NDC 63323-715, Fulvestrant, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-715
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210326
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-715-05 | 63323071505 | 2 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYRINGE, GLASS (63323-715-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fabe9bd8-ac23-4df1-a89a-223d5cd38914Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-715
Use it
Look up 63323-715 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.